Pleospora betae

Explore a selection of our essential drug information below, or:

CREATE FREE ACCOUNT

Full Drug Profiles

Unlock enhanced features & extensive drug insights, including detailed interaction data & regulatory status. Create a free account.

SUBSCRIBERECOMMENDED FOR PHARMA

Data Packages

Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Identification

Summary

Pleospora betae is an extract from Pleospora betae used in allergy testing.

Generic Name

Pleospora betae

DrugBank Accession Number

DB10936

Background

Pleospora betae is a fungus which can provoke allergic reactions. Pleospora betae extract is used in allergenic testing.

Type

Biotech

Groups

Approved

Biologic Classification

Allergenics
Allergen Extract

Synonyms

• Phoma extract

Get Early Access To DrugBank+

Be among the first to try our new AI-powered, game-changing platform. DrugBank+ is here to streamline your pharmaceutical research and deliver faster insights and smarter decisions.

Join the Waitlist

Get Early Access To DrugBank+

Join the Waitlist

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Unlock the secrets to drugging the undruggable

Discover how groundbreaking research is turning "undruggable" targets into therapeutic opportunities.

Download eBook

Unlock the secrets to drugging the undruggable

Download eBook

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Brand Name Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End	Region	Image
Phoma	Injection	0.1 g/1mL	Cutaneous; Intradermal; Subcutaneous	Allermed Laboratories, Inc.	1974-03-12	Not applicable
Phoma betae	Solution	0.025 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
Phoma betae	Solution	0.001 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
Phoma betae	Solution	0.05 g/1mL	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
New Stock Fungi Mix	Pleospora betae (0.00625 g/1mL) + Alternaria alternata (0.00625 g/1mL) + Aspergillus niger var. niger (0.00625 g/1mL) + Aureobasidium pullulans var. pullutans (0.00625 g/1mL) + Botrytis cinerea (0.00625 g/1mL) + Candida albicans (0.00625 g/1mL) + Chaetomium globosum (0.00625 g/1mL) + Cladosporium sphaerospermum (0.00625 g/1mL) + Cochliobolus sativus (0.00625 g/1mL) + Epicoccum nigrum (0.00625 g/1mL) + Gibberella fujikuroi (0.00625 g/1mL) + Mucor plumbeus (0.00625 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.00625 g/1mL) + Rhizopus stolonifer (0.00625 g/1mL) + Sarocladium strictum (0.00625 g/1mL) + Trichophyton mentagrophytes (0.00625 g/1mL)	Solution	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
New Stock Fungi Mix	Pleospora betae (1250 [PNU]/1mL) + Alternaria alternata (1250 [PNU]/1mL) + Aspergillus niger var. niger (1250 [PNU]/1mL) + Aureobasidium pullulans var. pullutans (1250 [PNU]/1mL) + Botrytis cinerea (1250 [PNU]/1mL) + Candida albicans (1250 [PNU]/1mL) + Chaetomium globosum (1250 [PNU]/1mL) + Cladosporium sphaerospermum (1250 [PNU]/1mL) + Cochliobolus sativus (1250 [PNU]/1mL) + Epicoccum nigrum (1250 [PNU]/1mL) + Gibberella fujikuroi (1250 [PNU]/1mL) + Mucor plumbeus (1250 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (1250 [PNU]/1mL) + Rhizopus stolonifer (1250 [PNU]/1mL) + Sarocladium strictum (1250 [PNU]/1mL) + Trichophyton mentagrophytes (1250 [PNU]/1mL)	Solution	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
New Stock Fungi Mix	Pleospora betae (0.0000625 g/1mL) + Alternaria alternata (0.0000625 g/1mL) + Aspergillus niger var. niger (0.0000625 g/1mL) + Aureobasidium pullulans var. pullutans (0.0000625 g/1mL) + Botrytis cinerea (0.0000625 g/1mL) + Candida albicans (0.0000625 g/1mL) + Chaetomium globosum (0.0000625 g/1mL) + Cladosporium sphaerospermum (0.0000625 g/1mL) + Cochliobolus sativus (0.0000625 g/1mL) + Epicoccum nigrum (0.0000625 g/1mL) + Gibberella fujikuroi (0.0000625 g/1mL) + Mucor plumbeus (0.0000625 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.0000625 g/1mL) + Rhizopus stolonifer (0.0000625 g/1mL) + Sarocladium strictum (0.0000625 g/1mL) + Trichophyton mentagrophytes (0.0000625 g/1mL)	Solution	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
New Stock Fungi Mix	Pleospora betae (0.003125 g/1mL) + Alternaria alternata (0.003125 g/1mL) + Aspergillus niger var. niger (0.003125 g/1mL) + Aureobasidium pullulans var. pullutans (0.003125 g/1mL) + Botrytis cinerea (0.003125 g/1mL) + Candida albicans (0.003125 g/1mL) + Chaetomium globosum (0.003125 g/1mL) + Cladosporium sphaerospermum (0.003125 g/1mL) + Cochliobolus sativus (0.003125 g/1mL) + Epicoccum nigrum (0.003125 g/1mL) + Gibberella fujikuroi (0.003125 g/1mL) + Mucor plumbeus (0.003125 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.003125 g/1mL) + Rhizopus stolonifer (0.003125 g/1mL) + Sarocladium strictum (0.003125 g/1mL) + Trichophyton mentagrophytes (0.003125 g/1mL)	Solution	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable
New Stock Fungi Mix	Pleospora betae (0.003125 g/1mL) + Alternaria alternata (0.003125 g/1mL) + Aspergillus niger var. niger (0.003125 g/1mL) + Aureobasidium pullulans var. pullutans (0.003125 g/1mL) + Botrytis cinerea (0.003125 g/1mL) + Candida albicans (0.003125 g/1mL) + Chaetomium globosum (0.003125 g/1mL) + Cladosporium sphaerospermum (0.003125 g/1mL) + Cochliobolus sativus (0.003125 g/1mL) + Epicoccum nigrum (0.003125 g/1mL) + Gibberella fujikuroi (0.003125 g/1mL) + Mucor plumbeus (0.003125 g/1mL) + Penicillium chrysogenum var. chrysogenum (0.003125 g/1mL) + Rhizopus stolonifer (0.003125 g/1mL) + Sarocladium strictum (0.003125 g/1mL) + Trichophyton mentagrophytes (0.003125 g/1mL)	Solution	Intradermal; Percutaneous; Subcutaneous	Greer Laboratories, Inc.	1981-09-15	Not applicable

Categories

Drug Categories

• Cell-mediated Immunity
• Increased Histamine Release
• Increased IgG Production
• Non-Standardized Fungal Allergenic Extract

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

V58BK047ES

CAS number

Not Available

References

General References

Not Available

External Links

PubChem Substance

347911031

RxNav

852756

Wikipedia

Pleospora_betae

Clinical Trials

Clinical Trials

Clinical Trial & Rare Diseases Add-on Data Package

Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package

Phase	Status	Purpose	Conditions	Count	Start Date	Why Stopped	100+ additional columns
Unlock 175K+ rows when you subscribe.View sample data

Unlock 75,000+ rows when you subscribe

Explore data packages curated & structured to speed up your pharmaceutical research

View Sample Data

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Solution	Intradermal; Percutaneous; Subcutaneous
Injection	Cutaneous; Intradermal; Subcutaneous	0.1 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.001 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.025 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.05 g/1mL

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53